NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Capital Expenditures (2015 - 2026)

NextPlat's (NXPL) quarterly Capital Expenditures came in at $53000.0 in Q2 2026, down 15.87% year-over-year from $63000.0 in Q2 2025, and up 200.0% quarter-over-quarter from -$53000.0 in Q1 2026.

Analysis

NextPlat (NXPL) Capital Expenditures (2015 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Capital Expenditures for 12 consecutive years, with $53000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Capital Expenditures fell 15.87% year-over-year to $53000.0 in Q2 2026; TTM through Jun 2026 was $37000.0, a 62.63% decrease from a year earlier, with the FY2025 full-year figure at $71000.0, down 62.43% from the prior year.
  • Capital Expenditures was $53000.0 for Q2 2026 at NextPlat, up from -$53000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $355000.0 in Q3 2023 and troughed at -$53000.0 in Q1 2026.
  • A 5-year average of $95470.6 and a median of $64000.0 in 2024 frame the typical range for Capital Expenditures.
  • Across the five-year window, Capital Expenditures jumped 14714.16% in 2022 and sank 145.31% in 2025, its largest moves.
  • Over 5 years, Capital Expenditures stood at $244882.0 in 2022, then retreated by 22.82% to $189000.0 in 2023, then tumbled by 116.93% to -$32000.0 in 2024, then surged by 215.62% to $37000.0 in 2025, then jumped by 43.24% to $53000.0 in 2026.
  • The last three Capital Expenditures figures came in at $53000.0 (Q2 2026), -$53000.0 (Q1 2026), and $37000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 104.00 Mn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 52.80 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn -36.19 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 30.70 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 77.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 3.05 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -27.87 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 8.59 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn -
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn 53,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53,000.00
Mar 31, 2026 -53,000.00
Dec 31, 2025 37,000.00
Jun 30, 2025 63,000.00
Mar 31, 2025 -29,000.00
Dec 31, 2024 -32,000.00
Sep 30, 2024 97,000.00
Jun 30, 2024 60,000.00
Mar 31, 2024 64,000.00
Dec 31, 2023 189,000.00
Sep 30, 2023 355,000.00
Jun 30, 2023 34,000.00
Mar 31, 2023 69,000.00
Dec 31, 2022 244,882.00
Sep 30, 2022 75,873.00
Jun 30, 2022 327,248.00
Mar 31, 2022 67,997.00
Dec 31, 2021 133,709.00
Sep 30, 2021 68,350.00
Jun 30, 2021 26,789.00